000 | 01627 am a22002053u 4500 | ||
---|---|---|---|
042 | _adc | ||
100 | 1 | 0 |
_aLiao, Chunyu _eauthor _92430 |
700 | 1 | 0 |
_aBeisel, Chase L. _eauthor _92431 |
245 | 0 | 0 | _aThe tracrRNA in CRISPR biology and technologies |
260 | _c2021-11-23. | ||
500 | _a/pmc/articles/PMC7614092/ | ||
500 | _a/pubmed/34416117 | ||
520 | _aCRISPR-Cas adaptive immune systems in bacteria and archaea utilize short CRISPR RNAs (crRNAs) to guide sequence-specific recognition and clearance of foreign genetic material. Multiple crRNAs are stored together in a compact format called a CRISPR array that is transcribed and processed into the individual crRNAs. While the exact processing mechanisms vary widely, some CRISPR-Cas systems including those encoding the Cas9 nuclease rely on a trans-activating crRNA (tracrRNA). The tracrRNA was discovered in 2011 and was quickly co-opted to create single-guide RNAs as core components of CRISPR-Cas9 technologies. Since then, further studies have uncovered processes extending beyond the tracrRNA's traditional role in crRNA biogenesis, revealed Cas nucleases besides Cas9 that are dependent on tracrRNAs, and established new applications based on tracrRNA engineering. In this review, we describe the biology of the tracrRNA and how its ongoing characterization has garnered new insights into prokaryotic immune defense and enabled key technological advances. | ||
540 | _a | ||
546 | _aen | ||
690 | _aArticle | ||
655 | 7 |
_aText _2local |
|
786 | 0 | _nAnnu Rev Genet | |
856 | 4 | 1 |
_uhttp://dx.doi.org/10.1146/annurev-genet-071719-022559 _zConnect to this object online. |
999 |
_c915 _d915 |